LGALS3 and chronic kidney disease: The study by Tuegel et al. [92] demonstrates that simultaneously determined high concentrations of three biomarkers in serum: galectin-3, sST2 and GDF-15 in patients with chronic kidney disease are associated with a higher mortality of such patients.